|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 17712970.7 (espacenet) (Federated) (European Patent Register), 20170322 | | Patent/reg. no. and date | DK/EP 3294270, 20180912 | | Publication date | 20180321 | | Priority no. and date | EP 16162415, 20160324 | | EP pub. no. and date |
EP 3294270 20180321 | | Effective date | | | Applicant/owner | Sandoz AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | | | Inventor | RANEBURGER, Johannes, c/o Sandoz GmbH
Biochemiestr. 10
6250 Kundl, AT | | Representative | | | Opponent | | | IPC Class | A61K 31/437 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) | | Title | PHARMACEUTICAL COMPOSITION CONTAINING RIFAXIMIN ALPHA&DELTA | | Int. application no. | EP2017056797 | | Int. publication no. | WO2017162725 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
